Diagnostics
On Target Laboratories announced that the first patient was treated in its Phase III trial of OTL38 in detecting ovarian cancer. Linked with a near-infrared dye, OTL38 allows surgeons to visually identify cancer cells that can guide them in removing the cancer tissue.
The new campus will consolidate some 400 employees in one place and give more space to the startup companies it helps.
The Dutch healthcare giant said that it also plans to invest in a service training program in Cleveland.
Mr Buccilli commenced with the Company in June 2014 as CFO and was appointed CEO in February 2015.
Last year, AmoyDx’s EGFR diagnostic was approved for use in the EU.
Topcon’s touted its system as being able to quickly penetrate ocular tissues without being obscured by hemorrhage or media opacities.
The first payments would have been due by Jan. 29, 2018.
Dr. Beall brings both radiology and pain management experience to the SAB.
The layoff leaves 58 percent of FDA employees on the job, which Gottlieb said is higher than the previous shutdown in 2013.
Life sciences professionals don’t have to look far for opportunity in Genetown.
PRESS RELEASES